The Role of Nutrition in Muscle Function of Bariatric Surgery Patients
Launched by CONCORDIA UNIVERSITY, MONTREAL · Nov 6, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "The Role of Nutrition in Muscle Function of Bariatric Surgery Patients," aims to understand how nutrition, particularly protein intake, affects muscle strength and overall health after bariatric surgery, which is a procedure to help people with obesity lose weight. Researchers want to find out how much protein patients should eat to help prevent muscle loss and maintain good health after their surgery. The study will involve around 75 participants, both men and women aged 18 to 65, who are planning to have their first bariatric surgery.
To be eligible for the study, participants must be non-smokers, not currently taking certain medications like Ozempic, and must not have any serious health issues that could limit their mobility. During the trial, participants will help researchers gather important information on how changes in diet and body composition relate to muscle function post-surgery. This research is important because it could help improve nutrition guidelines for people undergoing bariatric surgery, ensuring they receive the best care possible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female
- • Aged 18 to 65 years old
- • Undergoing first bariatric surgery (any type)
- • Diabetics and non-diabetics
- • Non-smokers and non-cannabis consumers
- Exclusion Criteria:
- • Pregnant and breastfeeding women
- • Individuals undergoing second bariatric surgery
- • Regular smokers and cannabis consumers
- • Current use of Ozempic (or Ozempic-like medication) and anti-psychotic meds
- • Limited physical mobility (using walking aids such as canes, walkers, or wheelchairs) and issues with hand resistance
- • Kidney disease, non-controlled / unstable hypertension and hypothyroidism, and any metabolic disease other than diabetes
About Concordia University, Montreal
Concordia University, located in Montreal, is a leading institution dedicated to advancing research and innovation in various fields, including health sciences. As a prominent clinical trial sponsor, Concordia University leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving patient outcomes and enhancing healthcare practices. The university fosters collaborations with industry partners and healthcare professionals, ensuring that its clinical trials adhere to the highest ethical standards and scientific integrity, while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported